| [1] | Kataoka Y,Shao M,Wolski K,et al.Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus[J].Eur J Prev Cardiol,2013,20(2):209-217. |
| [2] | Wang H,Liu J,Wang Q,et al.Descriptive study of possible link between cardioankle vascular index and homocysteine in vascular-related diseases[J].BMJ Open,2013,25,3(3):e002483. |
| [3] | Meye C,Schumann J,Wagner A,et al.Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells[J].Atherosclerosis,2007,190(2):256-263. |
| [4] | Zhang D,Chen Y,Xie X,et al.Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells[J].J Mol Cell Cardiol,2012,53(4):487-496. |
| [5] | Wilson AM,Swan JD,Ding H,et al.Widespread vascularlar production of C-reactive protein(CRP)and a relationship between serum CRP,plaque CRP and intimal hypertrophy[J].Atherosclerosis,2007,191(1):175-181. |
| [6] | Rietzschel E,De Buyzere M.High-sensitive C-reactive protein:universal prognostic and causative biomarker in heart disease?[J].Biomark Med,2012,6(1):19-34. |
| [7] | Singh U,Devaraj SJ,Vasquez-Vivar,et al.C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling[J].J Mol Cell Cardiol,2007,43(6):780-791. |
| [8] | Guo S,Wang R,Yang Z,et al.Effects of atorvastatin on serum lipids,serum inflammation and plaque morphology in patients with stable atherosclerotic plaques[J].Exp Ther Med,2012,4(6):1069-1074. |